BTC $64,945.35 -0.20%
ETH $1,919.74 -0.46%
BNB $595.41 +0.65%
XRP $1.03 +0.25%
SOL $75.36 +2.01%
TRX $0.3287 +0.36%
DOGE $0.0703 +0.74%
ADA $0.2000 -0.58%
BCH $216.57 -0.28%
LINK $8.33 +0.97%
HYPE $54.46 -4.01%
AAVE $90.26 +0.25%
SUI $0.6899 +2.11%
XLM $0.1635 +1.19%
ZEC $499.88 -2.10%
BTC $64,945.35 -0.20%
ETH $1,919.74 -0.46%
BNB $595.41 +0.65%
XRP $1.03 +0.25%
SOL $75.36 +2.01%
TRX $0.3287 +0.36%
DOGE $0.0703 +0.74%
ADA $0.2000 -0.58%
BCH $216.57 -0.28%
LINK $8.33 +0.97%
HYPE $54.46 -4.01%
AAVE $90.26 +0.25%
SUI $0.6899 +2.11%
XLM $0.1635 +1.19%
ZEC $499.88 -2.10%

Leap Therapeutics received $58.88 million in investment and purchased approximately 203,700 ZEC

2025-11-12 20:10:48

According to Decrypt, Nasdaq-listed company Leap Therapeutics announced the purchase of 203,775.27 ZEC tokens at an average price of $245 per token, and announced its transformation into a ZEC treasury company, which has been renamed Cypherpunk Technologies Inc.

In addition, the company also announced that it has secured $58.88 million in private financing led by Winklevoss Capital.

app_icon
ChainCatcher Building the Web3 world with innovations.